Projects per year
Abstract
Heart failure is one of the leading causes of death worldwide [1?4]. Current therapeutic strategies are inefficient
and cannot cure this chronic and debilitating condition [5]. Ultimately, heart transplants are required for patient
survival, but donor organs are scarce in availability and only prolong the life-span of patients for a limited time.
Fibrosis is one of the main pathological features of heart failure [6,7], caused by inappropriate stimulation of
fibroblasts and excessive extracellular matrix production. Therefore, an in-depth understanding of the cardiac fibroblast
is essential to underpin effective therapeutic treatments for heart failure [5]. Fibroblasts in general have
been an underappreciated cell type, regarded as relatively inert and providing only basic functionality; they are
usually referred to as the `biological glue? of all tissues in the body. However, more recent literature suggests that
they actively participate in organ homeostasis and disease [7,8].
We have recently uncovered a uniquemolecular identity for fibroblasts isolated from the heart [9], expressing a set
of cardiogenic transcription factors that have been previously associated with cardiomyocyte ontogenesis. This signature
suggests that cardiac fibroblasts may be ideal for use in stem cell replacement therapies, as they may retain
the memory of where they derive from embryologically. Our data also revealed that about 90 of fibroblasts from
both tail and heart origins share a cell surface signature that has previously been described for mesenchymal
stem cells (MSCs), raising the possibility that fibroblasts and MSCs may in fact be the same cell type. Thus, our findings
carry profound implications for the field of regenerativemedicine. Here,we describe detailedmethodology and
quality controls related to the gene expression profiling of cardiac fibroblasts, deposited at the Gene Expression Omnibus
(GEO) under the accession number GSE50531. We also provide the R code to easily reproduce the data quantification
and analysis processes.
| Original language | English |
|---|---|
| Pages (from-to) | 345 - 350 |
| Number of pages | 6 |
| Journal | Genomics Data |
| Volume | 2 |
| DOIs | |
| Publication status | Published - 2014 |
Projects
- 1 Finished
-
Systems modelling of the cardiac fibroblast
Boyd, S. (Primary Chief Investigator (PCI)) & Kitano, H. (Partner Investigator (PI))
ARC - Australian Research Council
3/01/13 → 21/12/16
Project: Research